Psychiatry & Neurology Doctors in Stroudsburg, PA Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Shobin Oommen, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1172 W Main St Ste B, Stroudsburg, PA 18360 Phone: 570-424-6187    Fax: 570-424-6271

Dr. Arthur Everett Middleton, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1172b West Main Street, Isl, Ltd, Stroudsburg, PA 18360 Phone: 570-424-6187

Harwant S Gill, MD PHD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 205 Applegate Rd Ste 1001133, Stroudsburg, PA 18360 Phone: 155-433-4882    Fax: 215-543-3488

Ilan S Levinson, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1172 West Main Street, Stroudsburg, PA 18360 Phone: 570-424-6187    Fax: 570-424-6271

News Archive

Study shows recombination among SARS-CoV-2 strains is already occurring, but remains rare

A recent study by U.S. researchers, currently available on the bioRxiv preprint server, indicates that the recombination events among the viral strains of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are already occurring – however, considering current levels of viral genetic diversity, they are neither widespread nor readily detectable.

Private cord blood banking can treat medical conditions but is expensive

Private cord blood banking is not cost-effective because it costs an additional $1,374,246 per life-year gained, according to a new analysis by UCSF researchers. The research team also concluded that private cord blood banking is cost-effective only for families with a child with a very high likelihood of needing a stem cell transplant.

Mesh-covered stent improves restoration of blood flow after PCI in heart attack patients

A clinical trial found that the use of a next generation, micronet, mesh-covered stent demonstrated improved restoration of blood flow to heart tissue, compared to the use of either bare-metal or drug-eluting stents in heart attack patients undergoing angioplasty.

Repligen first quarter total revenue increases 9% to $7,654,000

Repligen Corporation today reported results for the first quarter of fiscal year 2012, ended June 30, 2011.

Read more Medical News

› Verified 8 days ago